Functional Integration of Gut–Brain Axis and Fecal Microbiota Transplantation Therapy

2021 ◽  
pp. 253-290
Author(s):  
Rahul Mittal ◽  
Rahul Iyengar ◽  
Richard A. Skelton ◽  
Abdul Aljohani ◽  
Priyanka Sinha
Medicine ◽  
2020 ◽  
Vol 99 (35) ◽  
pp. e22035 ◽  
Author(s):  
Liu-Jun Xue ◽  
Xiao-Zhong Yang ◽  
Qiang Tong ◽  
Peng Shen ◽  
Shi-Jie Ma ◽  
...  

2019 ◽  
Vol 65 (4) ◽  
pp. 1107-1110 ◽  
Author(s):  
Natalia Castaño-Rodríguez ◽  
Sudarshan Paramsothy ◽  
Nadeem O. Kaakoush

2021 ◽  
Vol 5 (1) ◽  
pp. 004-009
Author(s):  
Ohara Tadashi

Currently, the emergence of highly virulent mutants in Europe and the United States has caused refractory recurrent Clostridium difficile infection (RCDI) to be a problem in clinical practice. In 2013, the Netherland group demonstrated breakthrough therapeutic efficacy in fecal microbial transplant (FMT) treatment clinical trials for RCDI, and FMT treatment is rapidly gaining attention. In addition to RCDI, FMT treatment has been attempted in various gastrointestinal diseases such as inflammatory bowel disease, irritable bowel syndrome and chronic constipation, as well as extragastrointestinal diseases. In this review, I would like to describe the current status, complications and prospects of FMT treatment.


Sign in / Sign up

Export Citation Format

Share Document